FDA Pediatric Oncology Workshop Will Define Advisory Committee Mission
Executive Summary
An FDA-sponsored workshop on pediatric oncology drug development will begin the process of redefining the agency's Pediatric Oncology Subcommittee
You may also be interested in...
Pediatric Oncology Subcmte. Should Discuss Timing Of Studies – Workshop
The Pediatric Oncology Subcommittee should determine when it is appropriate to initiate clinical testing of oncologic agents in children, participants at an FDA workshop on pediatric oncology drug development agreed
Pediatric Oncology Subcmte. Should Discuss Timing Of Studies – Workshop
The Pediatric Oncology Subcommittee should determine when it is appropriate to initiate clinical testing of oncologic agents in children, participants at an FDA workshop on pediatric oncology drug development agreed
Pediatric Access To Unapproved Drugs Is Next Topic For Oncology Subcmte
Pediatric use of unapproved cancer drugs will be the next topic on the table for FDA's Pediatric Subcommittee of the Oncologic Drugs Advisory Committee